MedTrace Logo

Validation of Aer-O-Scope Colonoscope System Cecal Intubation

NCT03949777 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 79

Last updated 2021-11-18

No results posted yet for this study

Summary

61 subjects (male or female) between the ages of 45 and 75 will undergo colonoscopy. The primary outcome is Cecal Intubation

Conditions

  • Colonic Polyp
  • Colonic Neoplasms
  • Colonic Diseases
  • Colon Adenoma
  • Colon Disease
  • Colon Adenocarcinoma
  • Colon Cancer

Interventions

DEVICE

Aer-O-Scope Colonoscopy

resection or biopsy of colonic abnormalities for histopathalogical evaluation

Sponsors & Collaborators

  • GI View Ltd.

    lead INDUSTRY

Principal Investigators

  • Nathan Gluck, MD · Tel Aviv Medical Center

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
45 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-01-06
Primary Completion
2021-08-10
Completion
2021-11-14

Countries

  • Israel

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03949777 on ClinicalTrials.gov